organic compounds
b][1,3,4]thiadiazole
of 3-benzylsulfanyl-6-(5-methyl-1,2-oxazol-3-yl)-1,2,4-triazolo[3,4-aDepartment of Chemistry, National Institute of Technology, Warangal, Telangana 506004, India, and bDepartment of Physics, Faculty of Sciences, Erciyes University, 38039 Kayseri, Turkey
*Correspondence e-mail: rajeswarnitw@gmail.com
In the title compound, C14H11N5OS2, the triazolo–thiadiazole system is essentially planar (r.m.s. deviation = 0.002 Å) and makes dihedral angles of 6.33 (12) and 42.95 (14)° with the planes of the oxazole and phenyl rings, respectively. In the crystal, face-to-face π–π interactions are observed between the thiadiazole and oxazole rings [centroid–centroid distance = 3.4707 (18) Å], leading to columns along [010].
Keywords: crystal structure; triazolo–thiadiazole system; isoxazole ring.
CCDC reference: 1425251
1. Related literature
For the pharmocological properties of isoxazole, see: Kuz'min et al. (2007); Yermolina et al. (2011); Lilienkampf et al. (2010); Kamal et al. (2011). For the bioactivity of 1,2,4-triazoles coupled with the thiadiazole heterocylic ring system, see: Singh & Singh (2009). For biological applications, such as antimicrobial, anticancer, antiviral and antihelmentic properties, see: Habib et al. (1997); Bhat et al. (2004); Farghaly et al. (2006); Khalil et al. (1999). For the synthesis, see: Vaarla & Rao (2014). For a similar structure, see: Dinçer et al. (2005).
2. Experimental
2.1. Crystal data
|
Data collection: APEX2 (Bruker, 2004); cell APEX2 and SAINT (Bruker, 2004); data reduction: SAINT and XPREP (Bruker, 2004); program(s) used to solve structure: SIR92 (Altomare et al., 1993); program(s) used to refine structure: SHELXL2014 (Sheldrick, 2015); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012); software used to prepare material for publication: WinGX (Farrugia, 2012) and PLATON (Spek, 2009).
Supporting information
CCDC reference: 1425251
https://doi.org/10.1107/S2056989015017351/tk5386sup1.cif
contains datablocks global, I. DOI:Structure factors: contains datablock I. DOI: https://doi.org/10.1107/S2056989015017351/tk5386Isup2.hkl
Supporting information file. DOI: https://doi.org/10.1107/S2056989015017351/tk5386Isup3.cml
The title compound was synthesized according to the published procedure (Vaarla & Rao, 2014). The compound was synthesized in two steps. In step one, a mixture containing equivalent amounts of 5-methylisoxazole-3-carboxylic acid and 4-amino-4H-[1,2,4]triazole-3,5-dithiol was refluxed in the presence of phosphorus oxychloride for about 5 h. After monitoring by TLC, the reaction mixture was cooled to room temperature and poured into crushed ice. The separated solid was filtered, dried and recrystallized from methanol.
In the second step the intermediate 6-(5-methylisoxazol-3-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole-3-thiol (1 eq.) was treated with benzyl bromide (1.1 eq.) in ethanol. The reaction mixture was refluxed for 5 h. After completion of the reaction, the reaction mixture was cooled to room temperature. The isolated solid product was filtered and washed with ethanol. Recrystallization was from ethanol.
All H atoms were placed in calculated positions with C—H = 0.93 to 0.97 Å, refined in the riding model with Uiso(H) parameters set to 1.2Ueq(C) or 1.5Ueq (CH3 only). The (0 0 - 2), (2 0 1) and (2 0 0) reflections, whose intensities were affected by the beamstop, were removed from the final refinement.
Nitrogen
have received much attention among researchers throughout the world for their applications as biological probes in the field of drug discovery. Isoxazole is a five membered O- and N-containing heterocylic compound and widely used as key building pharmacophore for drugs (Kuz'min et al., 2007; Yermolina et al., 2011; Lilienkampf et al., 2010; Kamal et al., 2011). Isoxazoles have a wide range of biological applications such as antiviral, anticancer, antibiotic, antituberculosis, antiinflammatory and antimicrobial agents, and as COX-2 inhibitors (Singh & Singh, 2009).A large number of [1,2,4] triazolo[3,4-b][1,3,4]thiadiazoles have remarkable biological applications such as antimicrobial (Habib et al., 1997), anticancer (Bhat et al., 2004), antiviral (Farghaly et al., 2006) and antihelmentic (Khalil et al., 1999) properties.
The title molecule is shown in Fig. 1. The plane of the triazolo-thiadiazole system [r.m.s. deviation = 0.002 Å] forms dihedral angles of 6.33 (12) and 42.95 (14)° with the oxazole (O1/N1/C2–C4) and phenyl (C9–C14) rings, respectively. All the bond lengths and bond angles in the compound are within normal ranges and comparable with those reported in a similar compound (Dinçer et al., 2005).
The π—π interactions [Cg1···Cg2 (x, -1 + y, z) = 3.4707 (18) Å and Cg2···Cg1 (x, 1 + y, z) = 3.4707 (18) Å] between the ring centroids, Cg1 and Cg2, of the thiadiazole and oxazole rings, respectively. Fig. 2 shows the molecular packing of the title compound down the b axis.
is stabilized by face-to-faceFor the pharmocological properties of isoxazole, see: Kuz'min et al. (2007); Yermolina et al. (2011); Lilienkampf et al. (2010); Kamal et al. (2011). For the bioactivity of 1,2,4-triazoles coupled with the thiadiazole heterocylic ring system, see: Singh & Singh (2009). For biological applications, such as antimicrobial, anticancer, antiviral and antihelmentic properties, see: Habib et al. (1997); Bhat et al. (2004); Farghaly et al. (2006); Khalil et al. (1999). For the synthesis, see: Vaarla & Rao (2014). For a similar structure, see: Dinçer et al. (2005).
Data collection: APEX2 (Bruker, 2004); cell
APEX2 and SAINT (Bruker, 2004); data reduction: SAINT and XPREP (Bruker, 2004); program(s) used to solve structure: SIR92 (Altomare et al., 1993); program(s) used to refine structure: SHELXL2014 (Sheldrick, 2015); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012); software used to prepare material for publication: WinGX (Farrugia, 2012) and PLATON (Spek, 2009).C14H11N5OS2 | F(000) = 680 |
Mr = 329.40 | Dx = 1.497 Mg m−3 |
Orthorhombic, Pca21 | Mo Kα radiation, λ = 0.71073 Å |
Hall symbol: P 2c -2ac | Cell parameters from 5610 reflections |
a = 16.271 (5) Å | θ = 5.0–55.6° |
b = 5.3804 (13) Å | µ = 0.37 mm−1 |
c = 16.700 (4) Å | T = 296 K |
V = 1462.0 (7) Å3 | Block, colourless |
Z = 4 | 0.50 × 0.45 × 0.30 mm |
Bruker Kappa APEXII CCD diffractometer | 3117 independent reflections |
Radiation source: fine-focus sealed tube | 2905 reflections with I > 2σ(I) |
Graphite monochromator | Rint = 0.027 |
ω and φ scan | θmax = 28.4°, θmin = 2.8° |
Absorption correction: multi-scan (SADABS; Bruker, 1999) | h = −20→21 |
Tmin = 0.836, Tmax = 0.896 | k = −6→7 |
10433 measured reflections | l = −16→21 |
Refinement on F2 | Hydrogen site location: inferred from neighbouring sites |
Least-squares matrix: full | H-atom parameters constrained |
R[F2 > 2σ(F2)] = 0.031 | w = 1/[σ2(Fo2) + (0.0411P)2 + 0.1925P] where P = (Fo2 + 2Fc2)/3 |
wR(F2) = 0.077 | (Δ/σ)max = 0.001 |
S = 1.08 | Δρmax = 0.18 e Å−3 |
3117 reflections | Δρmin = −0.20 e Å−3 |
200 parameters | Absolute structure: Flack (1983) |
1 restraint | Absolute structure parameter: 0.02 (2) |
C14H11N5OS2 | V = 1462.0 (7) Å3 |
Mr = 329.40 | Z = 4 |
Orthorhombic, Pca21 | Mo Kα radiation |
a = 16.271 (5) Å | µ = 0.37 mm−1 |
b = 5.3804 (13) Å | T = 296 K |
c = 16.700 (4) Å | 0.50 × 0.45 × 0.30 mm |
Bruker Kappa APEXII CCD diffractometer | 3117 independent reflections |
Absorption correction: multi-scan (SADABS; Bruker, 1999) | 2905 reflections with I > 2σ(I) |
Tmin = 0.836, Tmax = 0.896 | Rint = 0.027 |
10433 measured reflections |
R[F2 > 2σ(F2)] = 0.031 | H-atom parameters constrained |
wR(F2) = 0.077 | Δρmax = 0.18 e Å−3 |
S = 1.08 | Δρmin = −0.20 e Å−3 |
3117 reflections | Absolute structure: Flack (1983) |
200 parameters | Absolute structure parameter: 0.02 (2) |
1 restraint |
Geometry. Bond distances, angles etc. have been calculated using the rounded fractional coordinates. All su's are estimated from the variances of the (full) variance-covariance matrix. The cell e.s.d.'s are taken into account in the estimation of distances, angles and torsion angles |
Refinement. Refinement on F2 for ALL reflections except those flagged by the user for potential systematic errors. Weighted R-factors wR and all goodnesses of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The observed criterion of F2 > σ(F2) is used only for calculating -R-factor-obs etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger. |
x | y | z | Uiso*/Ueq | ||
S1 | 0.58876 (4) | 0.55792 (12) | 0.27749 (5) | 0.0430 (2) | |
S2 | 0.56435 (4) | 0.13539 (13) | 0.56223 (5) | 0.0480 (2) | |
O1 | 0.41434 (13) | 1.1668 (4) | 0.26095 (13) | 0.0513 (7) | |
N1 | 0.47539 (15) | 0.9833 (5) | 0.26294 (16) | 0.0500 (9) | |
N2 | 0.51832 (12) | 0.5539 (4) | 0.41898 (14) | 0.0359 (6) | |
N3 | 0.57592 (12) | 0.3670 (4) | 0.41555 (14) | 0.0348 (6) | |
N4 | 0.66919 (15) | 0.1462 (4) | 0.35159 (18) | 0.0478 (8) | |
N5 | 0.65754 (15) | 0.0517 (4) | 0.42870 (17) | 0.0464 (8) | |
C1 | 0.30250 (19) | 1.3389 (5) | 0.3361 (2) | 0.0539 (10) | |
C2 | 0.37083 (16) | 1.1579 (4) | 0.32957 (17) | 0.0396 (8) | |
C3 | 0.40056 (18) | 0.9771 (5) | 0.37679 (18) | 0.0415 (8) | |
C4 | 0.46538 (15) | 0.8755 (4) | 0.33223 (17) | 0.0350 (7) | |
C5 | 0.52042 (14) | 0.6671 (4) | 0.35064 (17) | 0.0342 (7) | |
C6 | 0.61891 (16) | 0.3354 (4) | 0.34707 (18) | 0.0381 (7) | |
C7 | 0.60185 (15) | 0.1833 (5) | 0.46600 (18) | 0.0388 (8) | |
C8 | 0.61793 (19) | 0.3882 (5) | 0.6143 (2) | 0.0488 (9) | |
C9 | 0.70934 (17) | 0.3711 (4) | 0.60716 (16) | 0.0391 (8) | |
C10 | 0.7528 (2) | 0.5388 (5) | 0.5610 (2) | 0.0523 (9) | |
C11 | 0.8368 (2) | 0.5174 (7) | 0.5528 (3) | 0.0639 (11) | |
C12 | 0.8789 (2) | 0.3276 (7) | 0.5891 (2) | 0.0603 (11) | |
C13 | 0.8372 (2) | 0.1623 (6) | 0.6353 (3) | 0.0628 (11) | |
C14 | 0.7532 (2) | 0.1828 (6) | 0.6448 (2) | 0.0556 (11) | |
H1A | 0.32400 | 1.49870 | 0.35070 | 0.0810* | |
H1B | 0.26440 | 1.28400 | 0.37630 | 0.0810* | |
H1C | 0.27480 | 1.35110 | 0.28550 | 0.0810* | |
H3 | 0.38240 | 0.93020 | 0.42740 | 0.0500* | |
H8A | 0.59980 | 0.54590 | 0.59240 | 0.0590* | |
H8B | 0.60300 | 0.38470 | 0.67050 | 0.0590* | |
H10 | 0.72510 | 0.66720 | 0.53530 | 0.0630* | |
H11 | 0.86540 | 0.63330 | 0.52220 | 0.0770* | |
H12 | 0.93530 | 0.31210 | 0.58220 | 0.0730* | |
H13 | 0.86540 | 0.03440 | 0.66070 | 0.0750* | |
H14 | 0.72560 | 0.06900 | 0.67690 | 0.0670* |
U11 | U22 | U33 | U12 | U13 | U23 | |
S1 | 0.0443 (3) | 0.0412 (3) | 0.0434 (4) | 0.0021 (3) | 0.0010 (3) | −0.0021 (3) |
S2 | 0.0399 (3) | 0.0460 (3) | 0.0582 (4) | −0.0038 (3) | 0.0005 (4) | 0.0125 (3) |
O1 | 0.0461 (11) | 0.0513 (11) | 0.0566 (15) | 0.0077 (8) | −0.0012 (9) | 0.0149 (10) |
N1 | 0.0457 (13) | 0.0496 (13) | 0.0546 (18) | 0.0096 (10) | 0.0017 (11) | 0.0107 (12) |
N2 | 0.0286 (10) | 0.0314 (10) | 0.0476 (13) | 0.0009 (7) | −0.0017 (9) | −0.0029 (9) |
N3 | 0.0276 (9) | 0.0299 (10) | 0.0470 (13) | 0.0001 (7) | −0.0024 (9) | −0.0055 (9) |
N4 | 0.0436 (13) | 0.0434 (12) | 0.0564 (15) | 0.0092 (10) | −0.0002 (12) | −0.0080 (11) |
N5 | 0.0415 (12) | 0.0367 (12) | 0.0611 (16) | 0.0062 (9) | −0.0050 (12) | −0.0029 (11) |
C1 | 0.0434 (15) | 0.0392 (14) | 0.079 (2) | 0.0064 (11) | −0.0022 (16) | 0.0071 (15) |
C2 | 0.0334 (12) | 0.0312 (12) | 0.0543 (17) | −0.0041 (9) | −0.0055 (11) | −0.0018 (12) |
C3 | 0.0426 (14) | 0.0345 (12) | 0.0474 (17) | 0.0023 (10) | −0.0002 (12) | 0.0018 (12) |
C4 | 0.0322 (11) | 0.0280 (10) | 0.0449 (15) | −0.0040 (8) | −0.0077 (10) | −0.0004 (10) |
C5 | 0.0303 (11) | 0.0272 (11) | 0.0450 (15) | −0.0033 (8) | −0.0048 (11) | −0.0058 (10) |
C6 | 0.0332 (12) | 0.0334 (11) | 0.0478 (15) | −0.0024 (9) | −0.0036 (12) | −0.0068 (11) |
C7 | 0.0312 (12) | 0.0342 (12) | 0.0509 (16) | −0.0024 (9) | −0.0054 (11) | −0.0011 (11) |
C8 | 0.0520 (17) | 0.0423 (14) | 0.0522 (18) | 0.0040 (12) | 0.0088 (14) | −0.0035 (13) |
C9 | 0.0451 (14) | 0.0368 (12) | 0.0354 (14) | −0.0027 (10) | 0.0008 (11) | −0.0051 (11) |
C10 | 0.0605 (17) | 0.0420 (14) | 0.0544 (17) | −0.0026 (12) | −0.0032 (17) | 0.0069 (14) |
C11 | 0.059 (2) | 0.0688 (19) | 0.064 (2) | −0.0199 (16) | 0.0027 (18) | 0.0050 (18) |
C12 | 0.0470 (17) | 0.072 (2) | 0.062 (2) | −0.0033 (15) | −0.0081 (15) | −0.0165 (18) |
C13 | 0.057 (2) | 0.0575 (19) | 0.074 (2) | 0.0046 (15) | −0.0232 (18) | 0.0005 (17) |
C14 | 0.0602 (19) | 0.0467 (16) | 0.060 (2) | −0.0040 (13) | −0.0082 (15) | 0.0126 (15) |
S1—C5 | 1.753 (3) | C8—C9 | 1.495 (4) |
S1—C6 | 1.739 (3) | C9—C10 | 1.382 (4) |
S2—C7 | 1.738 (3) | C9—C14 | 1.390 (4) |
S2—C8 | 1.835 (3) | C10—C11 | 1.378 (5) |
O1—N1 | 1.401 (3) | C11—C12 | 1.371 (5) |
O1—C2 | 1.348 (4) | C12—C13 | 1.359 (5) |
N1—C4 | 1.305 (4) | C13—C14 | 1.380 (5) |
N2—N3 | 1.376 (3) | C1—H1A | 0.9600 |
N2—C5 | 1.294 (4) | C1—H1B | 0.9600 |
N3—C6 | 1.351 (4) | C1—H1C | 0.9600 |
N3—C7 | 1.366 (4) | C3—H3 | 0.9300 |
N4—N5 | 1.397 (4) | C8—H8A | 0.9700 |
N4—C6 | 1.308 (3) | C8—H8B | 0.9700 |
N5—C7 | 1.308 (4) | C10—H10 | 0.9300 |
C1—C2 | 1.482 (4) | C11—H11 | 0.9300 |
C2—C3 | 1.342 (4) | C12—H12 | 0.9300 |
C3—C4 | 1.402 (4) | C13—H13 | 0.9300 |
C4—C5 | 1.468 (3) | C14—H14 | 0.9300 |
C5—S1—C6 | 86.79 (13) | C10—C9—C14 | 117.8 (3) |
C7—S2—C8 | 99.29 (14) | C9—C10—C11 | 120.6 (3) |
N1—O1—C2 | 109.1 (2) | C10—C11—C12 | 120.9 (3) |
O1—N1—C4 | 104.2 (2) | C11—C12—C13 | 119.3 (3) |
N3—N2—C5 | 106.8 (2) | C12—C13—C14 | 120.5 (3) |
N2—N3—C6 | 118.7 (2) | C9—C14—C13 | 121.0 (3) |
N2—N3—C7 | 135.6 (2) | C2—C1—H1A | 110.00 |
C6—N3—C7 | 105.7 (2) | C2—C1—H1B | 109.00 |
N5—N4—C6 | 104.6 (2) | C2—C1—H1C | 109.00 |
N4—N5—C7 | 109.6 (2) | H1A—C1—H1B | 109.00 |
O1—C2—C1 | 115.7 (2) | H1A—C1—H1C | 109.00 |
O1—C2—C3 | 109.6 (2) | H1B—C1—H1C | 109.00 |
C1—C2—C3 | 134.7 (3) | C2—C3—H3 | 128.00 |
C2—C3—C4 | 104.0 (3) | C4—C3—H3 | 128.00 |
N1—C4—C3 | 113.0 (2) | S2—C8—H8A | 109.00 |
N1—C4—C5 | 116.7 (2) | S2—C8—H8B | 109.00 |
C3—C4—C5 | 130.2 (3) | C9—C8—H8A | 109.00 |
S1—C5—N2 | 118.27 (17) | C9—C8—H8B | 109.00 |
S1—C5—C4 | 119.8 (2) | H8A—C8—H8B | 108.00 |
N2—C5—C4 | 121.9 (2) | C9—C10—H10 | 120.00 |
S1—C6—N3 | 109.44 (17) | C11—C10—H10 | 120.00 |
S1—C6—N4 | 138.7 (2) | C10—C11—H11 | 120.00 |
N3—C6—N4 | 111.9 (3) | C12—C11—H11 | 119.00 |
S2—C7—N3 | 124.7 (2) | C11—C12—H12 | 120.00 |
S2—C7—N5 | 127.1 (2) | C13—C12—H12 | 120.00 |
N3—C7—N5 | 108.2 (3) | C12—C13—H13 | 120.00 |
S2—C8—C9 | 112.91 (19) | C14—C13—H13 | 120.00 |
C8—C9—C10 | 120.9 (2) | C9—C14—H14 | 120.00 |
C8—C9—C14 | 121.3 (2) | C13—C14—H14 | 119.00 |
C5—S1—C6—N4 | 178.0 (3) | N5—N4—C6—N3 | −0.3 (3) |
C6—S1—C5—N2 | −0.6 (2) | N5—N4—C6—S1 | −178.5 (2) |
C6—S1—C5—C4 | −178.2 (2) | C6—N4—N5—C7 | 0.5 (3) |
C5—S1—C6—N3 | −0.21 (18) | N4—N5—C7—N3 | −0.4 (3) |
C8—S2—C7—N5 | 104.8 (3) | N4—N5—C7—S2 | 178.5 (2) |
C8—S2—C7—N3 | −76.5 (2) | C1—C2—C3—C4 | 178.8 (3) |
C7—S2—C8—C9 | −58.4 (2) | O1—C2—C3—C4 | −0.1 (3) |
N1—O1—C2—C1 | −179.0 (2) | C2—C3—C4—C5 | −178.1 (3) |
C2—O1—N1—C4 | −0.2 (3) | C2—C3—C4—N1 | −0.1 (3) |
N1—O1—C2—C3 | 0.1 (3) | C3—C4—C5—N2 | −5.1 (4) |
O1—N1—C4—C3 | 0.1 (3) | N1—C4—C5—S1 | −5.5 (3) |
O1—N1—C4—C5 | 178.5 (2) | N1—C4—C5—N2 | 176.9 (2) |
C5—N2—N3—C6 | −1.3 (3) | C3—C4—C5—S1 | 172.5 (2) |
N3—N2—C5—C4 | 178.7 (2) | S2—C8—C9—C10 | 109.4 (3) |
N3—N2—C5—S1 | 1.1 (3) | S2—C8—C9—C14 | −68.8 (3) |
C5—N2—N3—C7 | −178.4 (3) | C8—C9—C10—C11 | −178.1 (3) |
N2—N3—C7—S2 | −1.4 (4) | C14—C9—C10—C11 | 0.2 (5) |
N2—N3—C6—N4 | −177.8 (2) | C8—C9—C14—C13 | 177.4 (3) |
C6—N3—C7—N5 | 0.2 (3) | C10—C9—C14—C13 | −1.0 (5) |
C7—N3—C6—N4 | 0.1 (3) | C9—C10—C11—C12 | 1.0 (6) |
C7—N3—C6—S1 | 178.79 (17) | C10—C11—C12—C13 | −1.6 (6) |
N2—N3—C6—S1 | 0.9 (3) | C11—C12—C13—C14 | 0.9 (6) |
N2—N3—C7—N5 | 177.6 (3) | C12—C13—C14—C9 | 0.4 (6) |
C6—N3—C7—S2 | −178.7 (2) |
Experimental details
Crystal data | |
Chemical formula | C14H11N5OS2 |
Mr | 329.40 |
Crystal system, space group | Orthorhombic, Pca21 |
Temperature (K) | 296 |
a, b, c (Å) | 16.271 (5), 5.3804 (13), 16.700 (4) |
V (Å3) | 1462.0 (7) |
Z | 4 |
Radiation type | Mo Kα |
µ (mm−1) | 0.37 |
Crystal size (mm) | 0.50 × 0.45 × 0.30 |
Data collection | |
Diffractometer | Bruker Kappa APEXII CCD |
Absorption correction | Multi-scan (SADABS; Bruker, 1999) |
Tmin, Tmax | 0.836, 0.896 |
No. of measured, independent and observed [I > 2σ(I)] reflections | 10433, 3117, 2905 |
Rint | 0.027 |
(sin θ/λ)max (Å−1) | 0.669 |
Refinement | |
R[F2 > 2σ(F2)], wR(F2), S | 0.031, 0.077, 1.08 |
No. of reflections | 3117 |
No. of parameters | 200 |
No. of restraints | 1 |
H-atom treatment | H-atom parameters constrained |
Δρmax, Δρmin (e Å−3) | 0.18, −0.20 |
Absolute structure | Flack (1983) |
Absolute structure parameter | 0.02 (2) |
Computer programs: APEX2 (Bruker, 2004), APEX2 and SAINT (Bruker, 2004), SAINT and XPREP (Bruker, 2004), SIR92 (Altomare et al., 1993), SHELXL2014 (Sheldrick, 2015), ORTEP-3 for Windows (Farrugia, 2012), WinGX (Farrugia, 2012) and PLATON (Spek, 2009).
Acknowledgements
We are thankful to the Director N.I.T. Warangal for providing research facilities. KV express thanks to University Grants Commission–New Delhi (UGC) for a Senior Research Fellowship. The authors are thankful to SAIF–KOCHI–Cochin University, India, for providing the single crystal X-ray data.
References
Altomare, A., Cascarano, G., Giacovazzo, C. & Guagliardi, A. (1993). J. Appl. Cryst. 26, 343–350. CrossRef Web of Science IUCr Journals Google Scholar
Bhat, K., Prasad, D., Poojary, B. & Holla, B. (2004). Phosphorus Sulfur Silicon, 179, 1595–1603. Web of Science CrossRef CAS Google Scholar
Bruker (1999). SADABS. Bruker AXS Inc., Madison, Wisconsin, USA. Google Scholar
Bruker (2004). APEX2, SAINT and XPREP. Bruker AXS Inc., Madison, Wisconsin, USA. Google Scholar
Dinçer, M., Özdemir, N., Çetin, A., Cansız, A. & Büyükgüngör, O. (2005). Acta Cryst. C61, o665–o667. Web of Science CSD CrossRef IUCr Journals Google Scholar
Farghaly, A. R., De Clercq, E. & El-Kashef, H. (2006). Arkivoc, (x), 137–151. Google Scholar
Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849–854. Web of Science CrossRef CAS IUCr Journals Google Scholar
Flack, H. D. (1983). Acta Cryst. A39, 876–881. CrossRef CAS Web of Science IUCr Journals Google Scholar
Habib, N. S., Soliman, R., Ashour, F. A. & el-Taiebi, M. (1997). Pharmazie, 52, 844–847. CAS PubMed Web of Science Google Scholar
Kamal, A., Bharathi, E. V., Reddy, J. S., Ramaiah, M. J., Dastagiri, D., Reddy, M. K., Viswanath, A., Reddy, T. L., Shaik, T. B., Pushpavalli, S. N. & Bhadra, M. P. (2011). Eur. J. Med. Chem. 46, 691–703. Web of Science CrossRef CAS PubMed Google Scholar
Khalil, M. A., Raslan, M. A., Dawood, K. M. K. M. & Sayed, S. M. (1999). Heterocycl. Commun. 5, 463–472. CrossRef CAS Google Scholar
Kuz'min, V. E., Artemenko, A. G., Muratov, E. N., Volineckaya, I. L., Makarov, V. A., Riabova, O. B., Wutzler, P. & Schmidtke, M. (2007). J. Med. Chem. 50, 4205–4213. Web of Science PubMed CAS Google Scholar
Lilienkampf, A., Pieroni, M., Wan, B., Wang, Y., Franzblau, S. G. & Kozikowski, A. P. (2010). J. Med. Chem. 53, 678–688. Web of Science CrossRef CAS PubMed Google Scholar
Sheldrick, G. M. (2015). Acta Cryst. C71, 3–8. Web of Science CrossRef IUCr Journals Google Scholar
Singh, R. J. & Singh, D. K. (2009). S. Afr. J. Chem. 62, 105–108. CAS Google Scholar
Spek, A. L. (2009). Acta Cryst. D65, 148–155. Web of Science CrossRef CAS IUCr Journals Google Scholar
Vaarla, K. & Rao, V. R. (2014). J. Heterocycl. Chem. doi:10.1002/jhet.2168. Google Scholar
Yermolina, M. V., Wang, J., Caffrey, M., Rong, L. L. & Wardrop, D. J. (2011). J. Med. Chem. 54, 765–781. Web of Science CrossRef CAS PubMed Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
Nitrogen heterocyclic compounds have received much attention among researchers throughout the world for their applications as biological probes in the field of drug discovery. Isoxazole is a five membered O- and N-containing heterocylic compound and widely used as key building pharmacophore for drugs (Kuz'min et al., 2007; Yermolina et al., 2011; Lilienkampf et al., 2010; Kamal et al., 2011). Isoxazoles have a wide range of biological applications such as antiviral, anticancer, antibiotic, antituberculosis, antiinflammatory and antimicrobial agents, and as COX-2 inhibitors (Singh & Singh, 2009).
A large number of [1,2,4] triazolo[3,4-b][1,3,4]thiadiazoles have remarkable biological applications such as antimicrobial (Habib et al., 1997), anticancer (Bhat et al., 2004), antiviral (Farghaly et al., 2006) and antihelmentic (Khalil et al., 1999) properties.
The title molecule is shown in Fig. 1. The plane of the triazolo-thiadiazole system [r.m.s. deviation = 0.002 Å] forms dihedral angles of 6.33 (12) and 42.95 (14)° with the oxazole (O1/N1/C2–C4) and phenyl (C9–C14) rings, respectively. All the bond lengths and bond angles in the compound are within normal ranges and comparable with those reported in a similar compound (Dinçer et al., 2005).
The crystal structure is stabilized by face-to-face π—π interactions [Cg1···Cg2 (x, -1 + y, z) = 3.4707 (18) Å and Cg2···Cg1 (x, 1 + y, z) = 3.4707 (18) Å] between the ring centroids, Cg1 and Cg2, of the thiadiazole and oxazole rings, respectively. Fig. 2 shows the molecular packing of the title compound down the b axis.